Humana Inc. (NYSE:HUM) Given Average Rating of “Hold” by Analysts

Humana Inc. (NYSE:HUM) has been given a consensus rating of “Hold” by the twenty-eight ratings firms that are presently covering the stock, Marketbeat reports. Four analysts have rated the stock with a sell rating, fifteen have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $291.3478.

A number of research firms recently commented on HUM. Morgan Stanley raised their price target on shares of Humana from $217.00 to $249.00 and gave the stock an “underweight” rating in a research report on Thursday, June 4th. Oppenheimer raised shares of Humana from an “outperform” rating to an “outperform” rating in a research report on Wednesday, May 20th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Humana in a research report on Thursday. Deutsche Bank Aktiengesellschaft lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, May 20th. Finally, Barclays raised their price target on shares of Humana from $180.00 to $344.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 26th.

Humana Price Performance

NYSE:HUM opened at $379.42 on Friday. Humana has a 52 week low of $163.11 and a 52 week high of $379.50. The firm has a market cap of $45.55 billion, a price-to-earnings ratio of 40.58, a P/E/G ratio of 2.16 and a beta of 0.76. The firm’s 50-day simple moving average is $267.90 and its 200 day simple moving average is $237.20. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same period last year, the firm earned $11.58 earnings per share. Humana’s revenue for the quarter was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, sell-side analysts predict that Humana will post 9.04 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio (DPR) is currently 37.86%.

Hedge Funds Weigh In On Humana

Several hedge funds have recently bought and sold shares of the company. Long Focus Capital Management LLC bought a new stake in shares of Humana during the 3rd quarter valued at approximately $34,212,000. AMG National Trust Bank grew its holdings in shares of Humana by 106.5% during the 3rd quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock valued at $4,411,000 after purchasing an additional 8,744 shares during the last quarter. Aberdeen Group plc grew its holdings in shares of Humana by 18.1% during the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after purchasing an additional 43,442 shares during the last quarter. Alberta Investment Management Corp bought a new stake in shares of Humana during the 3rd quarter valued at approximately $4,735,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Humana by 4.1% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after purchasing an additional 9,960 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.